IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD)

CUSIP: 46333X108

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class
Equity / Class A common stock, $0.001 par value
Shares outstanding
162,690,355
Total 13F shares
175,222,861
Share change
+9,366,829
Total reported value
$2,020,512,624
Price per share
$11.53
Number of holders
229
Value change
+$105,001,683
Number of buys
120
Number of sells
106

Quarterly Holders Quick Answers

What is CUSIP 46333X108?
CUSIP 46333X108 identifies IRWD - IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) as of Q2 2022

As of 30 Jun 2022, IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (IRWD) was held by 229 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 175,222,861 shares. The largest 10 holders included BlackRock Inc., Sarissa Capital Management LP, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BROWN CAPITAL MANAGEMENT LLC, STATE STREET CORP, LSV ASSET MANAGEMENT, RENAISSANCE TECHNOLOGIES LLC, PUTNAM INVESTMENTS LLC, and CREDIT SUISSE AG/. This page lists 229 institutional shareholders reporting positions in this security for the Q2 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.